Howard Hughes Medical Institute Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$26.7K |
| 2 |
Robinhood
HOOD
|
+$18.1K |
| 3 |
Amazon
AMZN
|
+$10.2K |
| 4 |
Datadog
DDOG
|
+$9.5K |
| 5 |
XYZ
Block Inc
XYZ
|
+$8.91K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$96.2M |
| 2 |
Apple
AAPL
|
+$9.94K |
| 3 |
HES
Hess
HES
|
+$8.17K |
| 4 |
NVIDIA
NVDA
|
+$7.84K |
| 5 |
Microsoft
MSFT
|
+$7.14K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.56% |
| 2 | Financials | 0.95% |
| 3 | Consumer Discretionary | 0.76% |
| 4 | Communication Services | 0.75% |
| 5 | Healthcare | 0.64% |
Similar funds
Howard Hughes Medical Institute's Q3 2025 Portfolio in Review
As of Q3 2025, Howard Hughes Medical Institute held 509 positions worth $171M, down 32% from $251M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Howard Hughes Medical Institute withdrew a net $96.1M in Q3 2025, closing 9 positions and reducing 141 holdings. Its most notable exit was Hess, an estimated $8.17K position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.6% of assets, up from 1.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Howard Hughes Medical Institute opened a new position in Applovin worth $41.7K.
- Howard Hughes Medical Institute's largest Q3 2025 buy was Applovin: 58 shares worth $41.7K.
- Howard Hughes Medical Institute added most to Amazon in Q3 2025, an estimated $10.2K increase.
- Howard Hughes Medical Institute's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $96.2M.
- Howard Hughes Medical Institute fully exited Hess in Q3 2025, selling an estimated $8.17K.
- Howard Hughes Medical Institute's ten largest holdings make up 96% of its $171M portfolio in Q3 2025.
- Howard Hughes Medical Institute opened 8 new positions and closed 9 in Q3 2025.
- Howard Hughes Medical Institute's portfolio value fell 32% quarter-over-quarter to $171M.
Based on Howard Hughes Medical Institute's 13F filing for Q3 2025, filed 14 Nov 2025.